Sun Life Financial (SLF) Q1 2026 Earnings Call Summary

1Key Financial Results and Metrics

Underlying Net Income: $1.05 billion, a 4% increase year-over-year.

Earnings Per Share (EPS): Grew by 4% compared to Q1 2025.

Return on Equity (ROE): 18.6%, on track to meet the medium-term objective (MTO) of 20%.

Reported Net Income: $465 million, affected by market adjustments and one-time items, including a $165 million charge related to acquisitions and a $145 million legal provision.

Insurance Sales: Increased by 17% to $1.7 billion, with individual insurance sales reaching a record $1.2 billion (up 32%).

LICAT Ratio: 143%, down from 157% due to acquisitions and market impacts.

Dividend: Increased by 4% to $0.96 per share, with a renewed normal course issuer bid (NCIB) to repurchase up to 10 million shares.

2Strategic Updates and Business Highlights

Acquisitions: Completed the acquisitions of BGO and Crescent, enhancing the asset management platform.

Sales Growth: Significant growth in Asia with a 49% increase in sales, particularly in Hong Kong (75% increase).

Digital Initiatives: Continued investment in AI and digital capabilities to improve client experience and operational efficiency.

Asset Management: Strong gross flows and fundraising, with a focus on enhancing seed capital access and expanding capabilities.

U.S. Strategy: Focus on improving the dental business and increasing market share in commercial dental and medical stop-loss segments.

3Forward Guidance and Outlook

SLC Earnings: Expected to rebound solidly in the remainder of 2026, with a target of 20% compound annual growth rate (CAGR) for SLC.

Asia Growth: Continued strong performance anticipated, driven by high net worth and middle-class markets.

U.S. Business: Focus on scaling capital-light group benefits businesses, with expectations of improved profitability in stop-loss and dental segments.

4Bad News, Challenges, or Points of Concern

SLC Performance: Earnings below expectations due to the absence of catch-up fees and lower seed income compared to the previous year.

Market Impact: Reported net income affected by market conditions, including yield curve movements and real estate performance.

U.S. Dental Business: Ongoing challenges with Medicaid business leading to lower membership and revenue, although a strategic shift is underway.

LICAT Ratio Decline: Decreased from 157% to 143%, raising concerns about capital adequacy and organic capital generation.

5Notable Q&A Insights

LICAT Ratio Inquiry: Management clarified the decline was primarily due to the SLC acquisitions and market impacts, with a strong overall ratio still maintained.

Stop-Loss Business Performance: Improved morbidity experience noted, with specific figures requested by analysts to gauge the effectiveness of pricing actions.

U.S. Business Mix: Management emphasized a strategic focus on capital-light employee benefits and improving the dental business mix.

CSM Growth: Questions raised about the growth of Contractual Service Margin (CSM) in Canada, with management indicating expectations for positive growth aligned with medium-term objectives. Overall, SLF reported solid financial results with strong growth in key areas, particularly in Asia, while navigating challenges in certain segments and maintaining a focus on strategic initiatives and digital transformation.